Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANAGE: GI Tolerability of Tecfidera in Relapsing MS
NCT01873417Phase 4Completed
- Sponsor
- Biogen
- Start
- May 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Biogen. Started May 2013; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01873417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01873417.